Lupin

Lupin Official page of Lupin - A global pharmaceutical company with over 50 years of expertise in by prescriptions.
(265)

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions. The Company enjoys leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS) and women’s health areas. Lupin is the third largest pharmaceutical company in the U.S. The company invested 9.6% of its revenue on research and development in FY21. Lupin has 15 manufacturing sites, 7 research centers, more than 20,000 professionals working globally, and has been consistently recognized as a 'Great Place to Work' in the Biotechnology & Pharmaceuticals sector. Please visit www.lupin.com for more information.

16/02/2026

The only bone in your body built to handle the strongest force you can generate.
You use it every time you eat.
You use it every time you speak.
Can you guess which one it is?

At Lupin, every action we take is rooted in the belief that progress begins from within.When ideas turn into breakthroug...
16/02/2026

At Lupin, every action we take is rooted in the belief that progress begins from within.

When ideas turn into breakthroughs and small steps spark larger movements – that is when we truly act as catalysts.

Watch our CEO, Vinita Gupta, Managing Director, Nilesh Gupta, and Executive Director, Global CFO, and Head of API+, Sust...
13/02/2026

Watch our CEO, Vinita Gupta, Managing Director, Nilesh Gupta, and Executive Director, Global CFO, and Head of API+, Sustainability, and IT, Ramesh Swaminathan, discuss Lupin's Q3FY26 results with CNBC TV18.

Visit https://youtu.be/_j9FlC0VZJw

We are proud to announce that Lupin is officially certified as a Great Place to Work®, globally!This recognition is powe...
12/02/2026

We are proud to announce that Lupin is officially certified as a Great Place to Work®, globally!

This recognition is powered by our people - who, through their daily commitment, courage, and care, continue to push boundaries and create an environment where progress and possibility thrive.

Rooted in our Purpose – ‘we catalyze treatments that transform hope into healing’, this achievement celebrates the culture we continue to build across geographies and functions. It celebrates our collective commitment to creating a workplace where our values guide our actions and where every individual feels empowered to contribute and grow.

At Lupin, we will continue shaping a future where our people continue to set us apart and empower us to make a meaningful difference in the lives of those we serve.

12/02/2026

Purpose is not only about what we believe – it is also about how we act every day.

Let us hear from one of our colleagues, Yolanda Cervantes, on how her role goes beyond medicine, making her a catalyst for real impact.

At Lupin, our people are united by our shared purpose. Together, we strive to make a difference - advancing healthcare through dedication, responsibility, and a deep commitment to those we serve.

Everyone knows Indian pharma is a global force. Few know why it had to be.This carousel tells one of those origin storie...
11/02/2026

Everyone knows Indian pharma is a global force. Few know why it had to be.

This carousel tells one of those origin stories — the kind that doesn't make it to business school case studies. The kind where a childhood memory becomes a mission. Where ₹5,000 becomes millions of lives saved. Where "not profitable" becomes proof that Indian innovation was never about following the West's playbook.

Made in India by Manish Sabharwal and Sundeep Khanna uncovers these foundational moments. The ones that shaped not just companies, but how India approached problems the world had written off. The TB story is just one chapter. There are many more.

Because the real question isn't just "How did Indian pharma become what it is?" It is "What happens when an entire industry is built on making the impossible accessible?"

Swipe through. This one stays with you.

Made in India by Manish Sabharwal & Sundeep Khanna

Published by

"Whatever you are, you owe it to the society, and only by doing selfless service to the needy and the poorest of poor, o...
11/02/2026

"Whatever you are, you owe it to the society, and only by doing selfless service to the needy and the poorest of poor, one can achieve true sense of satisfaction and happiness; the highest purpose of life."

— Dr. Desh Bandhu Gupta

On the birth anniversary of our founder, Dr Desh Bandhu Gupta, we carry forward DBG's legacy by serving with purpose, compassion, and an unwavering commitment to societal well‑being.

Lupin Human Welfare & Research Foundation celebrated Seva Diwas by honouring DBG’s belief that caring for others is the greatest measure of success. His lifelong commitment to social upliftment continues to guide us as we work to strengthen rural India through sustainable, community‑led development.

Real change begins when people choose to lead with purpose.At Lupin, our purpose serves as a compass - driving us to cha...
10/02/2026

Real change begins when people choose to lead with purpose.

At Lupin, our purpose serves as a compass - driving us to challenge conventions, rethink what’s possible, and advance healthcare with intent.

This is how we transform hope into healing.

Our team in Goa came together to celebrate Sports Day with great energy, enthusiasm, and a strong sense of togetherness....
10/02/2026

Our team in Goa came together to celebrate Sports Day with great energy, enthusiasm, and a strong sense of togetherness. The day was a joyful reminder of the power of teamwork and the importance of creating moments where colleagues can connect, unwind, and cheer each other on.

The resilience, collaboration, and shared spirit seen throughout the celebrations truly reflect the values that guide us every day and reinforce our purpose — “To catalyze treatments that transform hope into healing.”

Made in India, written by Sundeep Khanna and Manish Sabharwal, traces three remarkable journeys: the rise of India’s pha...
09/02/2026

Made in India, written by Sundeep Khanna and Manish Sabharwal, traces three remarkable journeys: the rise of India’s pharma industry, the birth and evolution of Lupin and the extraordinary life of its founder, Desh Bandhu Gupta. Together, the three journeys illuminate how a country once completely dependent on imported medicines became the world's pharmacy.
To know more visit: https://bit.ly/4rBUR1f

Address

Mumbai

Opening Hours

Monday 9:30am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+912266402323

Website

Alerts

Be the first to know and let us send you an email when Lupin posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Lupin:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

A global pharmaceutical company with 50 years of expertise in bringing you better health with care.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions.

The Company enjoys leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS) and women’s health areas. Lupin is the third largest pharmaceutical company in the U.S. by prescriptions and in India by global revenues. The Company invests 9.6 % of its revenues on research and development.

Lupin has fifteen manufacturing sites, seven research centers, more than 20,000 professionals working globally, and has been consistently recognized as a 'Great Place to Work' in the Biotechnology & Pharmaceuticals sector.